Cannabis Could End Up Looking Like Big Pharma If Federal Rescheduling Leaves Social Equity Operators Behind (Op-Ed)
“Rescheduling should not become another step toward building a lucrative market that leaves that promise behind.” By Sasha Nutgent, Housing Works Cannabis Co Federal cannabis policy is beginning to change, but the benefits are not reaching every cannabis operator equally. In April, the federal government moved qualifying state-licensed medical cannabis from Schedule I of the […]
Marijuana Opponents And Pharma Company File Brief Asking Court To Block Trump’s Hemp CBD Medicare Coverage Plan
A coalition of anti-marijuana groups and a cannabis-focused biopharmaceutical corporation have filed a new brief in their lawsuit challenging the Trump administration’s initiative to cover up to $500 worth of hemp-derived products each year for eligible Medicare patients. In May, Judge Trevor N. McFadden dismissed the challenge to the Centers for Medicare & Medicaid Services […]